Premium
IO Biotech Inc (IOBT)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced imm... IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.2158 | -17.9833333333 | 1.2 | 1.24 | 0.9269 | 177348 | 1.06894229 | CS |
| 4 | 0.0642 | 6.97826086957 | 0.92 | 1.3699 | 0.831001 | 222437 | 1.10512816 | CS |
| 12 | 0.1042 | 11.8409090909 | 0.88 | 1.3699 | 0.773 | 165885 | 1.0228044 | CS |
| 26 | -0.0458 | -4.44660194175 | 1.03 | 1.3699 | 0.66 | 275901 | 0.91388808 | CS |
| 52 | -0.6858 | -41.0658682635 | 1.67 | 1.79 | 0.66 | 274798 | 1.03997401 | CS |
| 156 | -4.8058 | -83.0017271157 | 5.79 | 9.77 | 0.66 | 158151 | 1.5387874 | CS |
| 260 | -15.0158 | -93.84875 | 16 | 17.88 | 0.66 | 150452 | 2.20296671 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
